Latest filing published 02 Aug 2007 for TG Therapeutics, INC., €1,933.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Douglas Abel: trading record in brief
All filings by Douglas Abel on record concern TG Therapeutics, Inc. In total, 4 filings cover trades dated from 10 July 2006 to 1 August 2007.
No open-market sale appears; the market trades are 1 purchase worth €2,937. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants.
The latest filing, published on 2 August 2007, reports a share grant of €1,933 in TG Therapeutics, Inc. The clock since the last published purchase (10 July 2006) now reads 7,427 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Douglas Abel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.265Common StockSEC:0001144204-07-039802:0
- 10,000 shares@ US$0.36Common StockSEC:0001144204-07-037624:0
- 5,000 shares@ US$0.34Common StockSEC:0001144204-07-036878:0
- 5,000 shares@ US$0.75Common StockSEC:0001179110-06-014908:0Canonical exit: 8 Oct 2006 (T+90)
4 of 4 declarations